Effervescent tablet
US5171571A · kind A · utility
Inventors
Key dates
| Filing date | Apr 23, 1991 |
| Grant date | Dec 15, 1992 |
| Priority date | — |
| Expiry date | Apr 23, 2011 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
It is known to produce effervescent tablets incorporating salicyl acid analgetics gained synthetically, and, is required, vitamin adjuvants. In order to avoid the disadvantages of synthetically manufactured salicyl acid in such effervescent tablets, namely the irritation of the gastric mucosas and the inhibition of thrombocyte aggregation, and simultaneously to bring about new fields of use for effervescent tablets, an effervescent tablet is suggested which has, as an analgesic agent forming salicyclic acid, a water-soluble plant extract of the salicis extract type (willow bark extract) with a high active substance content. Thus, a galenically appropriate administration form of these generally extremely hygroscopic extracts is obtained. In the effervescent tablet, high active substance quantities can be resorbed rapidly, the salicyl acid forming the final active substance only being formed in the liver.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.